
Mark Andrew Hallman MD PhD
Urologic Cancer
Assistant Professor in Radiation Oncology
Join to view full profile
333 Cottman AvePhiladelphia, PA 19111
Phone+1 215-728-6900
Fax+1 215-214-4038
Dr. Hallman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Temple University Hospital/Fox Chase Cancer CenterResidency, Radiation Oncology, 2010 - 2014
Medical University of South Carolina College of MedicineInternship, Transitional Year, 2009 - 2010
Medical University of South CarolinaClass of 2009
University of the SciencesB.S., Pharmacology and Toxicology, Magna Cum Laude, 1994 - 1998
Certifications & Licensure
PA State Medical License 2010 - 2026
SC State Medical License 2009 - 2010
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- Alpha Omega Alpha Medical Honor Society 2009
Publications & Presentations
PubMed
- A Multimodal Artificial Intelligence Model to Guide Use of Whole-Pelvic Radiation Therapy in Patients with Localized Prostate Cancer: Exploratory Analysis of RTOG 9413.Mutlay Sayan, Huei-Chung Huang, Erin L Stewart, Timothy N Showalter, Adam P Dicker
Cancers. 2026-06-18 - A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer.Sebastian Medina, Naoto Tokuyama, Kamal Hammouda, Tilak Pathak, Tuomas Mirtti
Clinical Cancer Research. 2026-02-04 - 2 citationsComputed Tomography-Guided Online Adaptive Stereotactic Body Radiation Therapy for Liver Tumors: A Retrospective Study.Alexander Lukez, Li Zhang, Eric M Horwitz, Thomas J Galloway, Mark A Hallman
International Journal of Radiation Oncology, Biology, Physics. 2025-07-01
Journal Articles
- Radiation therapy to the primary tumor in locally advanced prostate cancer is not "closing the barn door after the horse has bolted"Zaorsky N, Smaldone MC, Annals of Translational Medicine, 1/1/2015
- Effect of antioxidants on para-aminophenol-induced toxicity in LLC-PK1 cellsTcaho R, Tarloff JB, Toxicology, 1/1/2000
Books/Book Chapters
Abstracts/Posters
- Impact of Regional Nodal Irradiation on Outcomes of Breast Cancer Patients with 1-3 Positive Axillary NodesKeller L, Anderson P, Tam T, ASTRO National Meeting, Boston, MA, 1/1/2012
- A Model of Redifferentiation in Primary Cultures of Regenerating Renal Proximal Tubule CellsHallman MA and Schnellmann RG, NIDDK – Kidney Development Injury and Repair Conference, Alexandria, VA, 1/1/2007
- Epidermal Growth Factor Receptor Regulates Dedifferentiation/Redifferentiation in Regenerating Renal Proximal Tubular CellsHallman MA and Schnellmann RG, Society of Toxicology – National Meeting, Charlotte, NC, 1/1/2007
Lectures
- Lung Stereotactic Body Radiation Therapy: Past, Present and FutureFox Chase Cancer Center, Philadelphia, PA - 1/10/2015
- Strategies in Lung Stereotactic Body Radiation TherapyFox Chase Cancer Center, Philadelphia, PA - 1/18/2014
- The Impact of Dose Heterogeneity on Local Recurrence (LR) Rates Following Stereotactic Body Radiotherapy (SBRT)San Francisco, CA - 1/1/2014
Grant Support
- EGF Receptor As A Therapeutic Target In Renal FailureNational Institute Of Environmental Health Sciences2004–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









